# FDG-PET-CT and Biomarkers in Esophageal Cancer

> **NCT00833625** · NA · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 31 (actual)

## Conditions studied

- Gastrointestinal Disease
- Esophageal Cancer

## Interventions

- **PROCEDURE:** PET/CT (FDG PET/CT)
- **OTHER:** Biomarker Testings

## Key facts

- **NCT ID:** NCT00833625
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2016-10-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00833625

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00833625, "FDG-PET-CT and Biomarkers in Esophageal Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00833625. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*